AorticLab™ is pleased to announce the successful achievement of CE certification for FLOWer™, an innovative transcatether embolic protection device (EPD) indicated for the cerebral and systemic protection of patients undergoing transcatheter aortic valve replacement (TAVI) procedures. The CE certification of FLOWer, a Class III medical...

AorticLab will attend the upcoming European HealthTech CEO Forum 2020, 18th February 2020, Hilton Zurich Airport Hotel, Switzerland. Presentation Time & Location: 10.40 – Track B – Room Berne – on 18th of February

San Francisco, CA. 25 September 2019, Dr. Filippo Scalise presented the AorticLab devices and development project at TCT innovator day at the Moscone Center. Speech title: Innovative protected transcatheter aortic valve calcium debridement system (AorticLab)